Article Information
History
- September 6, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 6, 2021 - 19:19).
- Version 2 (November 30, 2021 - 10:31).
- Version 3 (December 12, 2021 - 09:07).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sabine Hazan1,*,
- Neil Stollman2,
- Huseyin Bozkurt3,
- Sonya Dave4,
- Andreas J. Papoutsis1,
- Jordan Daniels1,
- Sibasish Dolai5,
- Bradley D. Barrows1,
- Eamonn MM Quigley6 and
- Thomas J. Borody5
- 1ProgenaBiome, Ventura, CA, USA
- 2Division of Gastroenterology, Alta Bates Summit Medical Center, Oakland CA
- 3Istanbul Maltepe University Medicine Faculty, Clinic of Gastroenterology, Istanbul, Turkey
- 4Microbiome Research Inc., Ventura, CA, USA
- 5Centre for Digestive Diseases, Five Dock, NSW, Australia
- 6Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, TX, USA
- ↵*Corresponding Author:
Sabine Hazan, ProgenaBiome, 1845 Knoll Drive, Ventura, CA 93003, USA., Tel: +1 800-380-0221, Email: drhazan{at}progenabiome.com
Posted September 06, 2021.
The missing microbes: Bifidobacterium and Faecalibacterium depletion and loss of microbiome diversity as potential susceptibility markers for SARS-CoV-2 infection and severity
